Reliability, Validity, and Cross-cultural Adaptation of the Turkish Version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire.

Study Overview

• Status: Completed
• Conditions: Gluteal Tendinitis; Greater Trochanteric Pain Syndrome of Both Lower Limbs
• Intervention / Treatment: Other: Survey study

Detailed Description

Gluteal tendinopathy, also known as greater trochanteric pain syndrome, interferes with physical function and sleep, and is characterized by pain and tenderness over the greater trochanter.Clinical risk factors for the development of this condition include advanced age, female gender, back pain, overweight / obesity, poor abductor hip function, altered gait parameters, and psychological distress. The Victorian Institute of Sports Assessment for Gluteal tendinopathy (VISA-G) Questionnaire has recently designed as a patient-reported condition-specific outcome measurement tool to assess disability due to tendinopathy. VISA-G is scored between 0 and 100 (a higher score is expected) and consists of eight items covering three main areas (pain, function, and current activity level). Visual analog score for pain (0-10), the effect of pain on weight-bearing activities (0-30), and difficulty and / or function-related stairs use, including lying on the symptomatic side (0-10), climbing ramps (0-10), standing up without sitting (0-10), home or garden work (0-10) and regular exercise (0-10), physical activity and sports participation (0-10) are evaluated. The study is planned with 40 individuals with gluteal tendinopathy. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in VISA-G, Short Form-36, International Physical Activity Questionnaire, Numeric Rating Scale, Oswestry Disability Index, Oxford Hip Score and modified Harris Hip Score.Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

• Study Type: Observational
• Enrollment (Actual): 108

Contacts and Locations

Study Locations

• Turkey
  • None Selected
    • Ankara, None Selected, Turkey, 06490
      • Halime ARIKAN

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Probability Sample

Study Population

The study population will consist of individuals with diagnosis of greater trochanteric pain syndrome and gluteal tendinopathy.

Description

Inclusion Criteria:

• Trochanteric bursitis and/or gluteal tendinopathy,
• Lateral hip pain,
• Pain on palpation of the greater trochanter,
• History of pain when lying on the ipsilateral side or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion Criteria:

• Hip osteoarthritis,
• Systemic inflammatory disease such as rheumatoid arthritis,
• Lumbar spine nerve root findings,
• History of lumbar spine or ipsilateral hip joint surgery,
• Osteogenic disease such as Paget's disease,
• Corticosteroid injection to the ipsilateral hip in the past 3 months,
• Hip surgery.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients group; Individuals with greater trochanteric pain syndrome and gluteal tendinopathy	Other: Survey study; Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire	Victorian Institute of Sports Assessment for Gluteal Tendinopathy Questionnaire is designed to assess disability due to gluteal tendinopathy.	10 minutes

Collaborators and Investigators

• Sponsor: Gazi University
• Investigators: Principal Investigator: Seyit CITAKER, Dr., Gazi University, Faculty of Health Sciences; Principal Investigator: M. Baybars ATAOGLU, Dr., Gazi University, Faculty of Medicine; Principal Investigator: Gokhan MARAS, MSc., Gazi University, Faculty of Health Sciences; Principal Investigator: Halime ARIKAN, MSc., Ankara University, Faculty of Health Sciences; Principal Investigator: I. Hazal AYAS, MSc., Gazi University, Faculty of Health Sciences; Principal Investigator: Beyza YAZGAN DAGLI, MSc., Gazi University, Faculty of Health Sciences

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2022
• Primary Completion (Actual): June 1, 2022
• Study Completion (Actual): July 1, 2022

Study Registration Dates

• First Submitted: January 10, 2021
• First Submitted That Met QC Criteria: January 10, 2021
• First Posted (Actual): January 13, 2021

Study Record Updates

• Last Update Posted (Actual): April 8, 2025
• Last Update Submitted That Met QC Criteria: April 6, 2025
• Last Verified: January 1, 2022

More Information

Terms related to this study

• Keywords: Validity; Reliability; Gluteal tendinopathy; Greater Trochanteric Pain Syndrome
• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Muscular Diseases; Wounds and Injuries; Joint Diseases; Tendon Injuries; Bursitis; Tendinopathy
• Other Study ID Numbers: E.137836

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Sharing Supporting Information Type: CSR

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No